Climaco Cano
Overview
Explore the profile of Climaco Cano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chavez-Castillo M, Nunez V, Rojas M, Ortega A, Duran P, Pirela D, et al.
Curr Pharm Des
. 2020 Jul;
26(35):4430-4443.
PMID: 32611293
At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) represents not only a pressing matter in public health but also a paramount object of study in biomedical research,...
12.
Chavez-Castillo M, Ortega A, Duran P, Pirela D, Marquina M, Cano C, et al.
Curr Pharm Des
. 2020 Apr;
26(35):4410-4429.
PMID: 32310044
At present, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, and global trends suggest that this panorama will persist or worsen in the near future. Thus,...
13.
Salazar J, Rojas-Quintero J, Cano C, Perez J, Ramirez P, Carrasquero R, et al.
Curr Cardiol Rev
. 2019 Jun;
16(1):25-35.
PMID: 31241018
Arterial hypertension is the most prevalent chronic disease in the adult population of developed countries and it constitutes a significant risk factor in the development of cardiovascular disease, contributing to...
14.
Palacio Rojas M, Prieto C, Bermudez V, Garicano C, Nunez Nava T, Martinez M, et al.
F1000Res
. 2018 Oct;
6:2073.
PMID: 30345000
The direct link between lipid metabolism alterations and the increase of cardiovascular risk are well documented. Dyslipidemias, including isolated high LDL-c or mixed dyslipidemia, such as those seen in diabetes...
15.
Bermudez V, Rojas J, Salazar J, Anez R, Toledo A, Bello L, et al.
J Diabetes Res
. 2015 May;
2015:750265.
PMID: 25945356
Introduction: The purpose of this study was to analyze the influence of metabolic phenotypes during the construction of ROC curves for waist circumference (WC) cutpoint selection. Materials And Methods: A...
16.
Bermudez V, Rojas J, Cordova E, Anez R, Toledo A, Aguirre M, et al.
Am J Ther
. 2013 Jul;
20(4):448-58.
PMID: 23838635
Sedentarism is considered a risk factor for coronary heart disease and death from any cardiovascular disease. The International Physical Activity Questionnaire (IPAQ) assesses physical activity in metabolic equivalents, using 4...
17.
Bermudez V, Rojas J, Salazar J, Bello L, Anez R, Toledo A, et al.
J Diabetes Res
. 2013 May;
2013:416451.
PMID: 23710466
Background: Lipoprotein(a) [Lp(a)] is a known risk factor for cardiovascular disease, yet its influence on metabolic syndrome (MS) is still controversial. The purpose of this study was to assess the...
18.
Bermudez V, Pacheco M, Rojas J, Cordova E, Velazquez R, Carrillo D, et al.
PLoS One
. 2012 Apr;
7(4):e35392.
PMID: 22530014
Introduction: Obesity is a worldwide public health issue. Since the epidemiological behaviour of this disease is not well established in our country, the purpose of this study was to determinate...
19.
Bermudez V, Arraiz N, Aparicio D, Rojas E, Gotera D, Guerra X, et al.
Am J Ther
. 2010 May;
17(3):263-73.
PMID: 20479580
Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoprotein genetic variants. Lp(a) contains a unique protein, apolipoprotein(a), which is linked to the Apo...
20.
Bermudez V, Marcano R, Cano C, Arraiz N, Amell A, Cabrera M, et al.
Am J Ther
. 2010 Jan;
17(3):288-94.
PMID: 20068446
The metabolic syndrome (MS) is a conglomerate of interrelated risk factors-including obesity, atherogenic dyslipidemia, arterial hypertension, and insulin resistance-which exponentially increase the risk of developing cardiovascular disease and type 2...